| 000 -LEADER |
|---|
| fixed length control field |
03396nam a22003977a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
1305198 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TSMU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200831174225.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
070420s2007 ne a b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2007016864 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780124054721 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM |
| Transcribing agency |
DNLM |
| Language of cataloging |
eng |
| 041 09 - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
2007 H-238 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 266 |
| Item number |
C2146 2007 |
| 080 ## - UNIVERSAL DECIMAL CLASSIFICATION NUMBER |
|---|
| Universal Decimal Classification number |
616-006 |
| Item number |
C-19 |
| 130 0# - MAIN ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Cancer immunotherapy (Prendergast) |
| 9 (RLIN) |
2455 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Cancer immunotherapy |
| Remainder of title |
: immune suppression and tumor growth / |
| Statement of responsibility, etc |
edited by George C. Prendergast, Elizabeth M. Jaffee. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Amsterdam ; |
| -- |
Boston : |
| Name of publisher, distributor, etc |
Elsevier/Academic Press, |
| Date of publication, distribution, etc |
c2007. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 409 p. : |
| Other physical details |
ill. |
| 365 ## - TRADE PRICE |
|---|
| Source of price type code |
336gel |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cancer immunoediting: from immune surveillance to immune escape / Ryungsa Kim -- Immunosurveillance: innate and adaptive antitumor immunity / Masahisa Jinushi and Glenn Dranoff -- Cytokine regulation of immune tolerance to tumors / Ming O. Li and Richard A. Flavell -- Immunological sculpting: natural killer cell receptors and ligands / David A. Sallman and Julie Y. Djeu -- Immune escape: immunosuppressive networks / Shuang Wei, Alfred Chang, and Weiping Zou -- Cytotoxic chemotherapy in clinical treatment of cancer / Rajesh Thirumaran, George C. Prendergast, and Paul B. Gilman -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Concepts in pharmacology and toxicology / Richard A. Westhouse and Bruce D. Car -- Cancer immunotherapy: challenges and opportunities / Andrew J. Lepisto, John R. McKolanis, and Olivera J. Finn -- Cancer vaccines / Freda K. Stevenson ... [et al.] -- |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Immunotherapy and cancer therapeutics: why partner? / Leisha A. Emens and Elizabeth M. Jaffee -- Immune stimulatory features of classical chemotherapy / Robbert G. van der Most, Anna K. Nowak, and Richard A. Lake -- Dendritic cells and coregulatory signals: immune checkpoint blockade to stimulate immunotherapy / Drew Pardoll -- Regulatory T cells in tumor immunity: role of toll-like receptors / Rong-Fu Wang -- Tumor-associated macrophages in cancer growth and progression / Alberto Mantovani, Paola Allavena and Antonio Sica -- Tumor-associated myeloid-derived suppressor cells / Stephanie K. Bunt ... [et al.] -- Programmed death ligand-1 and galectin-1: pieces in the puzzle of tumor-immune escape / Gabriel A. Rabinovich and Thomas F. Gajewski -- Indoleamine 2,3-dioxygenase in immune escape: regulation and therapeutic inhibition / Alexander J. Muller and George C. Prendergast -- Arginase, nitric oxide synthase, and novel inhibitors of L-arginine metabolism in immune modulation / Susanna Mandruzzato, Simone Mocellin, and Vincenzo Bronte. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
therapy |
| 9 (RLIN) |
199 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunotherapy |
| General subdivision |
methods |
| 9 (RLIN) |
1091 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic Agents |
| General subdivision |
therapeutic use |
| 9 (RLIN) |
1748 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Oncology |
| 9 (RLIN) |
5019 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ახალწარმონაქმნები |
| -- |
ანტიბლასტომური საშუალება სიმსივნის საწინააღმდეგო |
| -- |
იმუნოთერაპია |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ონკოლოგია |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Prendergast, George C. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Jaffee, Elizabeth M. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
წიგნი |